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Assessing renal graft function in clinical trials: Can tests predict-
ing glomerular filtration rate substitute for a reference method?
Background. In clinical trials, comparison of renal graft func-
tion needs a rigorous determination of glomerular filtration rate
(GFR). Since reference methods to measure GFR cannot be
easily implemented, a number of tests predicting GFR are usu-
ally used. However, little is known about their validity in renal
transplant patients. We aimed to compare the performances of
six GFR tests with inulin clearance in this population.
Methods. Five hundred consecutive inulin clearances per-
formed in 294 renal transplant recipients with stable renal
function were retrospectively selected. For each of them, we
computed six estimates: the 24-hour creatinine clearance, the
Cockcroft-Gault, Walser, Jelliffe, Nankivell, and Levey formu-
las. Their respective performance was assessed by correlation
(simple linear regression), accuracy (dispersion of true error),
and agreement (Bland and Altman method).
Results. Each GFR test closely correlated with inulin clear-
ance (P < 0.0001). Comparisons between pairs of GFR tests
did not show any significant difference in accuracy between
the Levey, Jelliffe, and Walser formulas. Conversely, each of
these formulas demonstrated a significant lower dispersion (P <
0.005) than the others. Nevertheless, all GFR tests displayed
considerable lack of agreement with limits of agreement over
40 mL/min/1.73 m2 apart. The proportion of predicted GFR dif-
fering from inulin clearance by ± 10 mL/min/1.73 m2, ranged
from 34% for the Jelliffe formula to 53% for the Nankivell’s
one.
Conclusion. None of these formulas seems to be able to safely
substitute for inulin clearance. In clinical trials, renal graft func-
tion should be preferably assessed using a reference method of
GFR measurement.
Key words: renal transplantation, inulin clearance, glomerular filtration
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Because chronic allograft dysfunction remains one of
the main causes of renal allograft loss, new strategies com-
bining the newer immunosuppressants are emerging in
order to improve long-term outcome [1, 2]. In this respect,
evaluation of new drugs regimens to prevent chronic re-
jection or to reduce calcineurin inhibitors nephrotoxic-
ity are in progress [3]. Since histologic changes are not
specific and may be misleading [4], assessment of these
special issues is, however, arduous, and graft function im-
pairment tends to be widely used as a surrogate marker of
chronic allograft damage. Therefore, comparison of renal
graft function is becoming a highly relevant end point in
clinical trials and rigorous determination of renal func-
tion in transplant recipients is of major concern.
The glomerular filtration rate (GFR) is considered as
the best overall index of renal function [5]. Exact quanti-
tative measurement of GFR requires the determination
of renal clearance of a marker freely filtered by the kidney
without undergoing any metabolism, tubular secretion or
reabsorption and thus, rapidly secreted in the urine by
glomerular filtration only. Inulin or synthetic inulin-like
polyfructosans fulfill these criteria and since its introduc-
tion in 1935 [6], renal clearance of inulin has remained the
gold standard for the measurement of GFR. Other ex-
ogenous markers have been advocated for this purpose
such as radiolabeled isotopes [51Cr ethylenediaminete-
traacetic acid (EDTA), 99mtechnetium (Tc) pentetic acid
(DTPA) or 125I iothalamate] and nonradioactive contrast
agents (iothalamate or iohexol). They are traditionally
also used as reference methods of GFR measurement [5].
Unfortunately, these methods, including inulin clearance,
cannot be easily implemented in clinical daily practice
because they are expensive, time-consuming, and cum-
bersome. To circumvent these drawbacks, a number of
tests predicting GFR have been proposed as reliable al-
ternatives for a suitable bedside assessment of renal func-
tion. However, most of these tests were developed from
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patients with chronic renal failure and data on their re-
spective performance in renal transplant patients are
scarce. In addition, statistic methods used to analyze their
validity are often inappropriate for a clinical research pur-
pose where the question is whether estimated GFR may
safely substitute to GFR measured by reference methods.
The aim of this study was to compare six differ-
ent GFR estimates (24-hour creatinine clearance and
five published equations) with inulin clearance in renal
transplant recipients according to their overall predic-
tive performance assessed by correlation, accuracy, and
agreement.
METHODS
Study population and GFR measurement
by inulin clearance
In our institution, inulin clearance is performed as part
of routine monitoring of renal graft function at 3 months,
1 year, 5 years, and thereafter every 5 years posttrans-
plantation. Five hundred consecutive inulin clearances
performed in our laboratory between November 1997
and January 2002 were retrospectively selected. These
500 clearances were measured in 294 renal transplant re-
cipients. It was a cross-sectional study. From the 500 inulin
clearances selected, 170 were performed at 3 months, 193
at 1 year, 79 at 5 years, and 58 beyond 5 years (10, 15, or
20 years) posttransplant. Regarding the patients, 101 had
one inulin measurement, 180 had two and 13 patients
had three inulin measurements. Inulin clearances were
selected from patients with a stable renal function, de-
fined as no acute rejection and no change in calcineurin
inhibitors dose during the month prior to inulin GFR
determination and a stable plasma creatinine concen-
tration since the last checkup. Patients undergoing in-
ulin clearance did not receive any concurrent therapy
with agents affecting tubular secretion of creatinine. Con-
cerning Pneumocystis carinii prophylaxis, sulfamethox-
azole/trimethoprime or sulfadoxine/pyrimethamine are
normally given every 2 weeks and taken the day after
of the procedure. The 500 inulin clearances retained for
analysis were all performed under a mean urine flow rate
over 2 mL/min.
The inulin clearance procedure started at 8:30 a.m.
after an overnight fasting. After a blank urine sample
was voided and a blood sample drawn, a loading dose
of 300 mg/kg (half-dose if serum creatinine concentra-
tion was over 160 lmol/L) of InutestTM 25% (Fresenius,
Linz, Austria) was given and continuous infusion of
400 mg/kg of inulin diluted in a 10% mannitol solution
was started for the measurement of GFR. After an equi-
libration period of 45 minutes, two clearance periods of
30 minutes each were analyzed. Urine samples were col-
lected by spontaneous voiding. In case of urine flow rate
differing by more than 0.1 mL/min between each period,
a new 30-minute clearance period was performed. Blood
samples, drawn from the arm opposite the infusion site,
were obtained at the midpoint of each clearance period.
Inulin concentrations were quantitated according to stan-
dard colorimetric assay (resorcinol method) on a UV1205
spectrophotometer (Shimadzu, Kyoto, Japan). GFR was
measured as the mean of at least two urinary clearances
of inulin with the formula UV/P, where U and P are inulin
concentration in urine and plasma and V is urine flow rate
(mL/min). GFR were expressed per 1.73 m2 of body sur-
face area by multiplying measured values by 1.73/body
surface area.
GFR estimates
For each inulin-determined GFR, six estimates were
performed from data recorded the day of the inulin clear-
ance procedure. Each predicted GFR was corrected for
1.73 m2 of body surface area:
24-hour creatinine clearance:
U.V
P
where U is urine creatinine concentration in lmol/L; V
is 24-hour urine volume in L; and P is serum creatinine
concentration in lmol/L.
Twenty-four–hour urine collection was done on the
day before the procedure, and plasma creatinine at start
of the procedure. Plasma and urine creatinine concen-
trations were measured with an enzymatic assay (Crea
Vitros; Ortho-Clinical Diagnostics, Issy-les-Moulineaux,
France).
Cockcroft-Gault formula [7]:
(140 − age) × weight
0.814 × serum creatinine
where age is in years, weight is in kg, serum creatinine in
lmol/L; × 0.85 for women.
Walser formula [8]:
For man
7.57 × (serum creatinine)−1 − 0.103
× age + 0.096 × weight − 6.66
For woman:
6.05 × (serum creatinine)−1 − 0.08
× age + 0.08 × weight − 4.81
where age is in years, weight is in kg, and serum creatinine
in mmol/L.
Jelliffe formula [9]:
98 − 16 × [(age − 20)/20]
serum creatinine
where age is in years, serum creatinine is in mg/dL; × 0.90
for women.
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Nankivell formula [10]:
6.7/serum creatinine + 0.25 × weight − 0.5 × urea − 0.01
× height2 + 35(25 for woman)
where serum creatinine is in mmol/L, weight is in kg, urea
is in mmol/L, and height is in m.
Levey formula [11]:
170 × serum creatinine−0.999 × age−0.176
× 0.762(if woman) × 1.180(if patient is black)
× blood ureanitrogen−0.170
× serum albumin concentration−0.318
where serum creatinine is in mg/dL, age is in years, blood
urea nitrogen is in mg/dL, and serum albumin concentra-
tion is in g/dL.
Statistics
All data were stored and analyzed using three differ-
ent software programs, StatView, Systat and a stan-
dard spreadsheet. P values below 0.05 were considered
significant.
Correlation between inulin clearance and GFR esti-
mates was studied computing simple linear regression
analyses. Pearson’s correlation coefficients are presented.
A new recently described statistical procedure was per-
formed to test accuracy [12]. This method, using a combi-
nation of different known mathematical processes, allows
the ranking and then comparison of the different GFR es-
timates to each other as well as to inulin clearance, accord-
ing to the standard deviation of their respective true error
(i.e., their true dispersion). Briefly, the determination of
the true error includes several successive steps. First, raw
errors are calculated. A linear regression is built between
the reference values, as the independent variables and
the observed original errors, as the dependent variables.
This initial step gives a set of raw errors, which are the
residuals of that regression line (i.e., the vertical distance
between the individual dependent values and the regres-
sion line). Second, raw errors are corrected for the sys-
tematic bias of the test (i.e., the value of the slope of the
linear regression). The third step transforms the set of raw
errors into a set of weighted errors by individually cor-
recting them according to the way they are grouped along
the regression line. The weighting factor, also called the
leverage, only depends on the reference value, while be-
ing independent from the measured error; in other words,
the leverage detects influential, but not aberrant data
points. The weighted errors are named true errors and
calculated as weighted error = raw residual/(1 − lever-
age)−2. The true error is thus the resulting raw error after
correction for the bias and appropriate weighting for dis-
persion.
Table 1. Descriptive statistics for inulin clearance and glomerular
filtration rate (GFR) estimates (mL/min per 1.73 m2)
Mean ± SD Median Range
Inulin clearance 49 ± 20 47 8–122
Creatinine clearance 56 ± 23 53 5–157
Cockcroft-Gault 53 ± 19 50 11–141
Walser 44 ± 16 43 8–97
Jelliffe 47 ± 15 46 12–118
Nankivell 57 ± 18 56 6–130
Levey 44 ± 17 41 9–117
Agreement was assessed by the Bland and Altman
method [13]. For each GFR estimate, a graph is con-
structed by plotting the difference between the estimated
and measured GFR against their mean. Ninety five per-
cent of differences lie between two limits defining the
interval of agreement: the lower limit, which is the mean
difference minus 2 standard deviations, and the upper
one, which is the mean difference plus 2 standard devia-
tions. Limits of agreement and respective 95% confidence
intervals for each predicting GFR formula are presented.
RESULTS
Descriptive statistics
The mean age (±SD) of recipients at the time of trans-
plantation was 45 ± 13 years. Of the patients, 68% were
male and 95% had received a kidney from a cadaveric
donor. Mean donor age was 36 ± 14 years. Causes of end-
stage renal disease (ESRD) were nondiabetic glomerular
disease (44%), diabetic glomerular disease (4%), poly-
cystic kidney disease (18%), congenital uropathy (12%),
and other or unknown renal diseases (22%). All patients
were initially treated with a calcineurin inhibitor (cy-
closporine A, 82%; tacrolimus, 18%)-based triple regi-
men but 35% were free of steroids at the time of GFR
measurement. A total of 37% of inulin clearances were
done in patients with a chronic allograft dysfunction de-
fined as a sustained increase in serum creatinine concen-
tration over 160 lmol/L regardless of etiology. Body mass
index (BMI) averaged 24 ± 4 kg/m2 and mean serum cre-
atinine concentration was 154 ± 87 lmol/L. Results for
the different methods of GFR determination are listed
in Table 1. Mean urine flow rate during inulin clearance
procedure was 3.6 mL/min (median 3; range 2 to 12). A
wide range of GFR was explored (from 8 to 122 mL/min
per 1.73 m2).
Correlation
The relations between predicted and measured GFR
are shown in Figure 1. Each GFR test displayed a highly
significant correlation (P < 0.0001) with inulin clearance.
Pearson’s correlation coefficients (r) varied from 0.67
for Cockcroft-Gault formula to 0.75 for Levey equation.
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Fig. 1. Correlation between inulin clearance
and six glomerular filtration rate (GFR) tests.
However, analysis of r2 pointed out that only 56.2% of the
interindividual variability for GFR predicted by Levey
equation was explained by true differences in inulin clear-
ance. This value was 54.8% for Jelliffe equation, 51.8%
for both Nankivell and Walser, and fell to 50.4% and
44.8% for 24-hour creatinine clearance and Cockcroft-
Gault formula, respectively.
Accuracy
The six GFR tests were ranked from the highest to the
lowest accuracy, according to their respective true error
dispersion against inulin clearance, as follows: (1) Levey
formula (true error SD = 13.4 mL/min); (2) Jelliffe for-
mula (true error SD = 13.6 mL/min); (3) Walser formula
(true error SD = 14.0 mL/min); (4) 24-hour creatinine
clearance (true error SD = 14.4 mL/min); (5) Cockcroft-
Gault formula (true error SD = 15.7 mL/min); and (6)
Nankivell formula (true error SD = 16.6 mL/min). Com-
parisons between pairs of tests predicting GFR are shown
in Table 2. There was no significant statistical difference
between Levey, Jelliffe, and Walser formulas. Conversely,
each of these formulas demonstrated a significantly lower
dispersion than 24-hour creatinine clearance, Cockcroft-
Gault, and Nankivell formulas. The latter, providing the
largest true error dispersion, was significantly less accu-
rate than all the others.
Agreement
Plots of the difference between predicted and mea-
sured GFR against their mean (Fig. 2) displayed a large
scattering of the data, enlightening the poor agreement
of each GFR test with inulin clearance. Limits of agree-
ment (Table 3) emphasized this lack of reliable agreement
between predicted and measured values. For example,
GFR estimated by Levey formula (which provided both
the best correlation and accuracy) may be 29 mL/min
per 1.73 m2 below or 28 mL/min per 1.73 m2 above in-
ulin clearance values. For all GFR estimates, limits of
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Table 2. Paired comparisons of accuracies of glomerular filtration rate (GFR) tests
Levey(TESD=13.4)
Jelliffe(TESD=13.6) NS
Walser(TESD=14.0) NS NS
24-hour creatinine clearance (TESD=14.4) P < 0.005 P < 0.001 P < 0.005
Cockcroft-Gault(TESD=15.7) P < 0.001 P < 0.005 P < 0.005 P < 0.001
Nankivell(TESD=16.6) P < 0.001 P < 0.001 P < 0.001 P < 0.001 P < 0.005
Levey Jelliffe Walser 24-hour creatinine clearance Cockcroft-Gault
Accuracy is assessed by the true error dispersion [true error standard deviation (TESD)] of each test against inulin clearance. GFR tests are ranked from the most
(Levey) to the least (Nankivell) accurate and compared to each other according to their respective accuracy.
NS is not significant.
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Fig. 2. Agreement between inulin clearance
and six glomerular filtration rate (GFR) tests
(Bland and Altman graphs). m is the mean of
the differences between measured and pre-
dicted GFR (bold line); m + 2 SD; and m −
2 SD are the upper and lower limits of the
interval of agreement, respectively.
agreement were more than 40 mL/min per 1.73 m2 apart.
To further address the degree of agreement, we com-
puted the proportion of both absolute differences (raw
errors) and relative differences (percent errors) between
predicted GFR and inulin clearance values beyond three
arbitrarily chosen thresholds (Tables 4 and 5). Of GFR
calculated by the Nankivell formula, 23% differed by
more or less 20 mL/min per 1.73 m2 with inulin clear-
ance. This proportion was 21% for both 24-hour creati-
nine clearance and Cockcroft-Gault formula, and 16%,
15%, and 13% for Walser, Levey, and Jelliffe formulas, re-
spectively. With a lower threshold, the great dispersion of
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Table 3. Limits of agreement of glomerular filtration rate (GFR)
tests (mL/min per 1.73 m2)
Lower limit (95% CI) Upper limit (95% CI)
Creatinine clearance −39 (−42; −37) 26 (24; 28)
Cockcroft-Gault −35 (−38; −33) 27 (25; 30)
Walser −23 (−25; −21) 33 (31; 35)
Jelliffe −26 (−28; −24) 29 (27; 31)
Nankivell −37 (−39; −35) 21 (18; 23)
Levey −29 (−31; −27) 28 (26; 30)
Table 4. Percentage of absolute differences over 20, 15, and
10 mL/min per 1.73 m2 between glomerular filtration rate (GFR) tests
and inulin clearance
Absolute Creatinine Cockcroft-
difference clearance Gault Walser Jelliffe Nankivell Levey
>20 21% 21% 16% 13% 23% 15%
>15 34% 33% 27% 22% 37% 24%
>10 44% 48% 38% 34% 53% 41%
Table 5. Percentage of relative differences over 20, 15, and 10%
between glomerular filtration rate (GFR) tests and inulin clearance
Relative Creatinine Cockcroft-
difference % clearance Gault Walser Jelliffe Nankivell Levey
>20 50% 54% 47% 43% 57% 43%
>15 59% 64% 58% 53% 66% 56%
>10 74% 76% 72% 68% 77% 70%
absolute errors became more apparent. The proportion
of absolute errors over 10 mL/min per 1.73 m2 varied from
53% for the Nankivell formula to 34% for the Jelliffe (Ta-
ble 4). Regarding to the percent errors, more than 40%
of calculated GFR had an error over 20% whatever the
GFR test used (Table 5). In addition, we compared the
prediction of the GFR tests at different time points after
transplantation, dividing our 500 inulin clearances popu-
lation into three subgroups: (1) inulin clearances done at
3 months (N = 170); (2) inulin clearances done at 1 year
(N = 193); and (3) inulin clearances done at and beyond
5 years (N = 137) (Table 6) (Fig. 3). We observed that,
for all the GFR tests, prediction seemed to be improved
with time, but nervertheless, without ever reaching a rel-
evant level of agreement. In the subgroup of inulin clear-
ances performed at and beyond 5 years posttransplant,
the Levey equation provided the best prediction but 38%
of GFR calculated by this formula still had an error over
20% (Table 6). Interestingly, we also noticed that, what-
ever the time after transplantation, there was a trend to-
ward a slighty better prediction for Walser, Jelliffe, and
Levey formulas (Fig. 3).
Since obesity and extreme values of GFR may im-
pair the reliability of tests predicting GFR, we assessed
agreement in patients with BMI less than 30 kg/m2 and
with inulin clearance-measured GFR ranging from 20
to 80 mL/min per 1.73 m2. These subgroup analyses did
Table 6. Percentage of relative differences over 20% between
glomerular filtration rate (GFR) tests and inulin clearance at three
different time points after transplantation: at 3 months (N = 170); at
1 year (N = 193); and beyond 5 years (N = 137) posttransplant
Creatinine Cockcroft-
clearance Gault Walser Jelliffe Nankivell Levey
3 months 54% 60% 50% 44% 65% 50%
1 year 52% 53% 48% 46% 56% 43%
≥5 years 45% 53% 42% 40% 52% 38%
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Fig. 3. Comparison of six glomerular filtration rate (GFR) tests in the
whole population and at different time points posttransplant accord-
ing to the proportion (%) of estimated GFR with a relative difference
against inulin clearance, over 20%.
not show any improvement in predictive performance of
GFR estimate (data not shown).
DISCUSSION
Although it has been suggested that filtration of in-
ulin may be impaired in renal transplant recipients [14],
use of inulin clearance as the gold standard for measure-
ment of GFR has never been reconsidered in renal trans-
plantation. In clinical nephrology as in transplantation,
every alternative method, currently used as a reference
to measure GFR, was validated against inulin clearance
or against a renal clearance of a marker which had been
first compared to inulin clearance [15, 16]. Neverthe-
less, a weak variability of inulin clearance measurement
is required to assert its reliability in the specific trans-
plant population. Since repeatability of inulin clearance
in renal transplantation is scarcely documented, we have
addressed this issue in our laboratory. We performed
duplicate determinations in a group of eight renal trans-
plant recipients covering a wide range of renal function.
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We found a mean intraindividual coefficient of varia-
tion of 8.4% (unpublished data), close to that given by
inulin clearance in nontransplant patients [5]. On the
other hand, a careful measurement of urine volume is
crucial to achieve an optimal inulin clearance procedure.
To minimize error inherent in an incomplete and inac-
curate timed urine collection, we studied several collec-
tion periods and only inulin clearances performed un-
der a sustained urine flow rate were retained. Therefore,
though unwieldy, the standard constant infusion clear-
ance of inulin as performed in this study, is likely to insure
an accurate measurement of true GFR in renal transplant
recipients.
The six methods of GFR estimate were tested against
inulin clearance according to a combination of differ-
ent statistical analyses giving a comprehensive picture of
their respective performance. Correlation coefficient, r,
measures the strength of the relationship between pre-
dicted and true GFR and more precisely, analysis of r2
indicates how much variability of predicted GFR account
for variability of measured GFR. Correlation analysis
is commonly used in studies testing a predictive model
against a reference method and thus, computing r from
our cohort may allow a comparison with previously pub-
lished data. However, a significant correlation only means
that the null hypothesis of no relationship between GFR
tests and inulin clearance may be rejected. We clearly
need more information to assess performance of a test
predicting GFR. Both accuracy and agreement better
characterize its validity. Each GFR test was classified
according to its relative accuracy after identification of
true errors between predicted and measured GFR. We
compared them to each other to know whether one or
many significantly provide a more accurate prediction.
Agreement indicates how well GFR tests will substitute
for the reference standard itself [13], which is probably
the most informative way to describe their predictive per-
formances and to ascertain that they may safely replace
inulin clearance in the specific setting of clinical trials.
Taken together, the statistic methods we processed allow
to finely probe relevance of a GFR test in assessing renal
graft function.
The 24-hour creatinine clearance is an excellent mea-
surement of GFR in normal subjects, but only a gross
estimate in case of renal impairment because of tubu-
lar secretion of creatinine and of a great intra- and
interindividual variability [17]. Despite the fact that sev-
eral investigators have explicitly recommended that mea-
surement of creatinine clearance be abandoned [17–19],
it is still frequently used. Since an inaccurate urine col-
lection may further compromise its performance, many
formulas, including Cockcroft-Gault and Jelliffe, have
been developed to estimate creatinine clearance from
the plasma creatinine alone. Cockcroft and Gault first
published their equation in 1976 [7]. Since that time, it
has arguably become the most widely used GFR test in
the clinical as well as in the research setting. The form
of the Jelliffe equation we tested was first published as
a letter to the editor in 1973 [9] and includes only age
and serum creatinine, making it very attractive for a bed-
side GFR estimation. Interestingly enough, Cockcroft-
Gault and Jelliffe equations only provide an estimate of
creatinine clearance, which is, in turn, an approximation
of GFR. However, their respective performances have
been tested against reference methods in several different
patient populations, including renal allograft recipients
[10, 20, 21]. Conversely, the Walser, Levey, and Nankiv-
ell equations attempt to estimate GFR rather than cre-
atinine clearance. The Walser equation [17] was initially
developed in comparison to urinary clearance of 99mTc
DTPA from a cohort of 85 patients with moderate to
severe chronic renal failure (serum creatinine concentra-
tion ≥177 lmol/L) but has since been studied in renal
transplant population spanning the whole range of GFR
values usually encountered [21]. Levey derived different
predictive equations from 1628 patients included in the
Modification of Diet in Renal Disease (MDRD) Study
and undergoing renal clearance of 125I iothalamate [11].
We selected here the equation that included only demo-
graphic and serum variables and gave one of the most
accurate predictions. Of the GFR tests we studied, the
Nankivell formula is the only one which has been com-
puted initially from a renal transplant population in which
GFR were measured by plasma 99mTc DTPA clearance
[10]. Of note, this equation has already been used to as-
sess renal graft function in clinical trials [22].
The correlation coefficients we report, although com-
parable, are not strictly similar with those previously pub-
lished in transplant patients. For the Cockcroft-Gault
formula, Pearson’s coefficients equal to 0.83 and 0.71
have already been reported [10, 23]. In our cohort, we
found a less optimistic r of 0.67. These different values
may stress that results are partly dependent on the study
population characteristics. Moreover, in our study, we de-
termined plasma creatinine concentration with an enzy-
matic method. Eliminating interference with chromogens
other than creatinine, such an assay is probably better
suited for accurate GFR estimation than the commonly
used Jaffe´ assay [24]. Since it usually gives lesser values
of plasma creatinine concentration, it may have affected
the comparison of our results with previously published
ones. Nevertheless, as expected, we note that estimated
GFR are strongly related with true GFR.
In term of accuracy, the Levey, Walser, and Jelliffe
equations are quite similar and together better than the
other tested models. Consistent with this result, Goerdt
et al [21] found that Jelliffe and Walser formulas give
the most precise estimation of GFR in renal transplant
patients. Up to now, the performance of Levey equa-
tion has only been partially documented in this specific
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population of patients [abstract; Bedros F et al, J Am Soc
Nephrol 9:666A, 1998].
In addition, our data underline the poor predictive
performance of measured creatinine clearance. Many in-
vestigators have reported that it may be improved by
blocking tubular creatinine secretion with an oral admin-
istration of cimetidine [17]. However, the dose and timing
of cimetidine required to completely inhibit tubular se-
cretion of creatinine dramatically vary from one patient
to another. More recently, Kemperman et al [25] con-
cluded that predictive performance of Cockcroft-Gault
formula 24 hours after 2400 mg of cimetidine was sig-
nificantly enhanced in renal allograft recipients. Never-
theless, this cimetidine-modified Cockcroft and Gault
formula was validated for patients with a plasma cre-
atinine concentration less than 180 lmol/L and, con-
sequently, may be implemented only on this restricted
population.
Assessment of agreement indicates that, despite highly
significant correlation and different degrees of accuracy,
none of the six GFR tests demonstrates an acceptable
agreement with inulin clearance since they conceal dis-
crepancies up to 39 mL/min per 1.73 m2. Whatever the
model tested, the limits of agreement are not small
enough to be confident that it can be used in place of
a reference method. This is particularly true in clinical
trials investigating a therapeutic strategy designed to im-
prove graft function and which aim to compare at one
point the mean predicted GFR between two groups. In
such trials, it may appear relevant to detect an improve-
ment of 10 mL/min in GFR. It is clearly not when GFR
is estimated with one of the models we tested here, since
more than one third of the predicted values differ from
true GFR by more than 10 mL/min. In the same way,
we can consider a difference between predicted and true
GFR, lower than 20% as acceptable. But once again, we
can hardly use one of these tests, given that, at the best,
43% of estimated values are beyond this threshold.
One may notice that, since most of patients had re-
peated measurements of inulin, all our data are not in-
dependent. However, we performed additional anlysis
including only 294 inulin clearances done in the 294 pa-
tients and found quite similar results (data not shown).
Surprisingly, the Nankivell equation does not display a
better GFR estimation. To our knowledge, one study be-
fore ours has investigated the performance (only judged
on correlation) of this formula and also pointed out that
GFR prediction was not better compared to formulas
derived from nontransplant patients [abstract; Bedros F
et al, J Am Soc Nephrol 9:666A, 1998].
CONCLUSION
In nephrology as well as in transplantation, many in-
vestigators have cautioned against using GFR estimates
for a clinical research purpose [5, 26]. Our study suggests
that the overall performance of the 24-hour creatinine
clearance, the Cockcroft-Gault, Jelliffe, Walser, Nankiv-
ell, and Levey equations does not allow a rigorous as-
sessment of renal graft function. These GFR tests exhibit
a good correlation with inulin clearance, but they all dis-
play considerable lack of agreement. Although the Levey,
Walser, and Jelliffe equations demonstrate a better ac-
curacy than the others, we conclude that none of these
formulas seems to be able to safely substitute for inulin
clearance. In clinical trials, renal graft function should
be preferably assessed using a reference method of GFR
measurement.
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